Business Context and Reporting Period
This Form 8-K Current Report, filed on June 11, 2020, covers events occurring on June 10 and June 11, 2020, for LivaNova PLC, a medical technology company incorporated in England and Wales. The filing details the entry into a material definitive credit agreement and the announcement of a concurrent offering of exchangeable senior notes.
Key Financial Metrics and Debt Structure
The filing focuses on capital structure changes rather than operating performance metrics such as revenue or profit, which are not provided in this document.
- Term Loan Facility: A delayed draw term loan facility of $450 million was established with Ares Capital Corporation as the administrative agent.
- Senior Notes: The company announced a concurrent offering of $250 million in cash exchangeable senior notes due 2025.
- Interest Rate: The Term Loan bears interest at LIBOR (with a 1.0% floor) plus 6.5% per annum, or a Base Rate plus an applicable margin.
- Maturity: The Term Loan matures on June 30, 2025.
- Use of Proceeds: Proceeds from the Term Loan and Notes are intended to repay outstanding indebtedness under existing credit facilities, pay costs for capped call transactions, and fund general corporate purposes.
Material Changes and Covenants
The primary material change is the restructuring of debt obligations through the new Credit Agreement. The agreement imposes specific financial maintenance covenants:
- Minimum Net Revenue: Consolidated net revenue must not be lower than $700 million for each trailing 12-month period (decreasing pro rata to a floor of $550 million upon certain asset sale prepayments).
- Secured Leverage Ratio:
- 5.625:1.00 for the period ending June 30, 2021.
- 4.50:1.00 for periods ending September 30, 2021, and thereafter.
- Prepayment Penalties: A make-whole premium applies to prepayments within two years of closing. Prepayment premiums of 2.0% and 1.0% apply in the third and fourth years, respectively.
Outlook, Risks, and Contingencies
The filing outlines significant risks associated with the new debt instruments:
- Conditions Precedent: Funding is contingent on satisfying customary conditions, including the receipt of proceeds from the Notes offering.
- Events of Default: Defaults include non-payment, insolvency, material misrepresentation, failure to comply with covenants, and receipt of exchange notices under the Notes exceeding $25 million unless equivalent junior indebtedness is raised.
- Restrictions: Negative covenants restrict additional indebtedness, asset sales, dividends, and fundamental changes to the company.
- Security: Obligations are secured by a first-priority security interest in substantially all tangible and intangible assets of Holdings and certain subsidiaries.
Investor Verification Checklist
- Verify the closing date and actual disbursement of the $450 million Term Loan.
- Confirm the successful pricing and issuance of the $250 million exchangeable senior notes.
- Review the specific terms of the capped call transactions entered into in connection with the Notes.
- Monitor compliance with the $700 million minimum net revenue covenant and the 5.625:1.00 leverage ratio for the upcoming fiscal quarters.
- Assess the impact of the new debt service obligations on future cash flow and liquidity.